(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.

The three most active and biggest winners today are Tesla, Smith & Wesson, and Union Pacific Corporation.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Tesla (TSLA) 795.90 2.67% 2021-10-04 07:10:50
2 Smith & Wesson (SWBI) 21.31 1.82% 2021-10-04 07:12:59
3 Union Pacific Corporation (UNP) 205.33 1.78% 2021-10-04 07:17:32
4 Best Buy Co. (BBY) 107.00 1.6% 2021-10-04 07:14:07
5 HDFC Bank Limited (HDB) 74.82 1.51% 2021-10-04 06:16:02
6 Novo Nordisk A/S (NVO) 97.27 1.45% 2021-10-04 07:16:35
7 Entergy Corporation (ETR) 100.60 1.24% 2021-10-04 07:15:14
8 CME Group (CME) 198.98 1.22% 2021-10-04 07:07:47
9 United Airlines (UAL) 51.88 1.05% 2021-10-04 07:13:13
10 American Airlines (AAL) 21.87 1.02% 2021-10-04 07:07:12

The three most active and biggest losers today are Moderna, Arcturus Therapeutics, and Novavax.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Moderna (MRNA) 325.04 -4.71% 2021-10-04 07:12:27
2 Arcturus Therapeutics (ARCT) 42.51 -4.3% 2021-10-04 07:11:27
3 Novavax (NVAX) 174.75 -3.77% 2021-10-04 07:09:56
4 Canaan (CAN) 6.21 -3.12% 2021-10-04 07:11:42
5 Seattle Genetics (SGEN) 168.53 -2.7% 2021-10-04 07:10:26
6 Toyota (TM) 172.99 -2.61% 2021-10-04 07:17:27
7 Pinduoduo (PDD) 86.03 -2.41% 2021-10-04 07:12:38
8 Xenetic Biosciences (XBIO) 2.03 -2.4% 2021-10-04 07:13:22
9 Pacific Biosciences of California (PACB) 25.25 -2.28% 2021-10-04 07:10:04
10 Fox Corporation (FOXA) 39.86 -2.26% 2021-10-04 07:08:44

Most Active Premarket Winners today

1. Tesla (TSLA) – Premarket: 2.67%

NASDAQ Composite ended the session with Tesla dropping 0.03% to $775.22 on Monday, following the last session’s downward trend. NASDAQ Composite jumped 0.82% to $14,566.70, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

Volume

Today’s last reported volume for Tesla is 17031400, 10.65% below its average volume of 19063100.

Tesla’s last close was $775.22, 13.9% below its 52-week high of $900.40.

News about Tesla today

  • Tesla top wallstreetbets interest heading into new week, amc, wish, tilray and these are other top trends. According to today’s article on Benzinga, "Read Next: Nikola’s $2B Lawsuit Against Tesla Days Away From Dismissal: What Investors Should Know", "Price Action: SPDR S&P 500 ETF Trust’s shares closed almost 1.2% higher in Friday’s trading at $434.24, while Tesla shares closed less than 0.1% lower at $775.22."

Tesla’s Sales

Tesla’s sales growth is 49.9% for the ongoing quarter and 37.7% for the next. The company’s growth estimates for the current quarter and the next is 81.6% and 102.5%, respectively.

Tesla’s Revenue

Year-on-year quarterly revenue growth grew by 73.6%, now sitting on 35.94B for the twelve trailing months.

Volatility

Tesla’s last week, last month’s, and last quarter’s current volatility was 2.84%, 2.84%, and 1.68%, respectively.

Tesla’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.87% (last week), 2.87% (last month), and 1.68% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Tesla’s stock is considered to be overbought (>=80).

Tesla’s Stock Yearly Top and Bottom Value

Tesla’s stock is valued at $775.22 at 08:34 EST, way under its 52-week high of $900.40 and way above its 52-week low of $379.11.

Tesla’s Moving Average

Tesla’s value is higher than its 50-day moving average of $733.84 and way above its 200-day moving average of $676.57.

Previous days news about Tesla

  • Tesla seen set for delivery record, beating supply-chain turmoil. According to Bloomberg Quint on Friday, 1 October, "Twelve analysts surveyed by Bloomberg expect Tesla to report 223,677 deliveries in the third quarter. ", "A strong figure would show that Tesla is holding up well as it and other automakers face global supply-chain turmoil. "
  • Elon Musk's Tesla accuses rivian of poaching employees, stealing battery secrets. According to Benzinga on Sunday, 3 October, "Now apparently under pressure from investors after nearly a dozen years without producing a single commercial vehicle, Rivian has intensified its unlawful efforts," Tesla said in the filling.", "Rivian responded,saying there is not enough evidence to justifyTesla’s claims."For several of its trade secrets, it has provided so little detail that Rivian is unable to ascertain what Tesla is claiming as its intellectual property, let alone whether what it is claiming is or could be secret," Rivian said in a filing."
  • Tesla amps up rivian poaching fight, cites battery secrets theft. According to Bloomberg Quint on Sunday, 3 October, "Here, defendants contend that Tesla has not alleged plausible facts to support its contention that defendants acquired confidential battery information," he wrote. ", "A California state court judge in San Jose allowed Tesla last week to add its new allegations to the pending case, along with three more of its former employees as defendants. "
  • Tesla Q3 deliveries steamroll past estimates, defying supply chain shocks and China demand uncertainty. According to Benzinga on Saturday, 2 October, "Related Link: EV Week In Review: Tesla Pushes Out FSD Broader Beta Rollout, Chinese Trio Delivers, Ford Doubles Down On EV Investment, Lordstown’s Prudent Strategy", "Tesla Q3 Deliveries Sizzle: Tesla reported third-quarter deliveries of 241,300 vehicles, beating the consensus estimate of 233,000. "

More news about Tesla.

2. Smith & Wesson (SWBI) – Premarket: 1.82%

NASDAQ Composite ended the session with Smith & Wesson rising 0.82% to $20.93 on Monday while NASDAQ Composite rose 0.82% to $14,566.70.

Volume

Today’s last reported volume for Smith & Wesson is 874759, 46.43% below its average volume of 1633060.

Smith & Wesson’s last close was $20.93, 47.16% below its 52-week high of $39.61.

The company’s growth estimates for the current quarter is 41.9% and a drop 6.3% for the next.

Smith & Wesson’s Revenue

Year-on-year quarterly revenue growth grew by 19.5%, now sitting on 1.1B for the twelve trailing months.

Volatility

Smith & Wesson’s last week, last month’s, and last quarter’s current volatility was a negative 3.66%, a negative 3.66%, and a positive 2.21%, respectively.

Smith & Wesson’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.48% (last week), 4.48% (last month), and 2.21% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Smith & Wesson’s stock is considered to be oversold (<=20).

Smith & Wesson’s Stock Yearly Top and Bottom Value

Smith & Wesson’s stock is valued at $20.93 at 08:34 EST, way below its 52-week high of $39.61 and way higher than its 52-week low of $14.50.

Smith & Wesson’s Moving Average

Smith & Wesson’s worth is below its 50-day moving average of $22.43 and under its 200-day moving average of $22.09.

More news about Smith & Wesson.

3. Union Pacific Corporation (UNP) – Premarket: 1.78%

NYSE Composite ended the session with Union Pacific Corporation rising 2.92% to $201.74 on Monday, following the last session’s upward trend. NYSE Composite rose 1.11% to $16,323.74, following the last session’s upward trend on what was an all-around up trend exchanging session today.

Volume

Today’s last reported volume for Union Pacific Corporation is 3468590, 11.73% above its average volume of 3104230.

Union Pacific Corporation’s last close was $201.74, 12.76% below its 52-week high of $231.26.

The company’s growth estimates for the present quarter and the next is 30.8% and 14.4%, respectively.

Union Pacific Corporation’s Revenue

Year-on-year quarterly revenue growth grew by 29.7%, now sitting on 20.57B for the twelve trailing months.

Volatility

Union Pacific Corporation’s last week, last month’s, and last quarter’s current volatility was a negative 3.36%, a negative 1.26%, and a positive 1.01%, respectively.

Union Pacific Corporation’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 6.28% (last week), 1.99% (last month), and 1.01% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Union Pacific Corporation’s stock is considered to be oversold (<=20).

Union Pacific Corporation’s Stock Yearly Top and Bottom Value

Union Pacific Corporation’s stock is valued at $201.74 at 08:34 EST, way under its 52-week high of $231.26 and way above its 52-week low of $171.50.

Union Pacific Corporation’s Moving Average

Union Pacific Corporation’s value is under its 50-day moving average of $212.17 and under its 200-day moving average of $218.93.

More news about Union Pacific Corporation.

4. Best Buy Co. (BBY) – Premarket: 1.6%

NYSE Composite ended the session with Best Buy Co. dropping 0.38% to $105.31 on Monday while NYSE Composite jumped 1.11% to $16,323.74.

Volume

Today’s last reported volume for Best Buy Co. is 2091700, 7.11% below its average volume of 2251990.

Best Buy Co.’s last close was $105.31, 18.09% below its 52-week high of $128.57.

The company’s growth estimates for the present quarter and the next is a negative 11.7% and a negative 16.7%, respectively.

Best Buy Co.’s Revenue

Year-on-year quarterly revenue growth grew by 35.9%, now sitting on 50.34B for the twelve trailing months.

Volatility

Best Buy Co.’s last week, last month’s, and last quarter’s current volatility was a negative 4.12%, a negative 4.12%, and a positive 1.72%, respectively.

Best Buy Co.’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.12% (last week), 4.12% (last month), and 1.72% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Best Buy Co.’s stock is considered to be overbought (>=80).

Best Buy Co.’s Stock Yearly Top and Bottom Value

Best Buy Co.’s stock is valued at $105.31 at 08:34 EST, way under its 52-week high of $128.57 and higher than its 52-week low of $95.93.

Best Buy Co.’s Moving Average

Best Buy Co.’s worth is under its 50-day moving average of $112.01 and under its 200-day moving average of $114.63.

More news about Best Buy Co..

5. HDFC Bank Limited (HDB) – Premarket: 1.51%

NYSE Composite ended the session with HDFC Bank Limited jumping 0.85% to $73.71 on Monday while NYSE Composite jumped 1.11% to $16,323.74.

Volume

Today’s last reported volume for HDFC Bank Limited is 2362590, 70.16% above its average volume of 1388410.

HDFC Bank Limited’s last close was $73.71, 12.98% below its 52-week high of $84.70.

The company’s growth estimates for the current quarter and the next is 14.5% and 14.1%, respectively.

HDFC Bank Limited’s Revenue

Year-on-year quarterly revenue growth grew by 15.5%, now sitting on 804.01B for the twelve trailing months.

Volatility

HDFC Bank Limited’s last week, last month’s, and last quarter’s current volatility was a negative 2.01%, a negative 2.01%, and a positive 1.17%, respectively.

HDFC Bank Limited’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.86% (last week), 2.86% (last month), and 1.17% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

HDFC Bank Limited’s stock is considered to be oversold (<=20).

HDFC Bank Limited’s Stock Yearly Top and Bottom Value

HDFC Bank Limited’s stock is valued at $73.71 at 08:34 EST, way under its 52-week high of $84.70 and way above its 52-week low of $52.16.

HDFC Bank Limited’s Moving Average

HDFC Bank Limited’s worth is below its 50-day moving average of $75.59 and below its 200-day moving average of $74.17.

More news about HDFC Bank Limited.

6. Novo Nordisk A/S (NVO) – Premarket: 1.45%

NYSE Composite ended the session with Novo Nordisk A/S falling 0.14% to $95.88 on Monday, after four successive sessions in a row of losses. NYSE Composite rose 1.11% to $16,323.74, following the last session’s upward trend on what was an all-around up trend trading session today.

Volume

Today’s last reported volume for Novo Nordisk A/S is 815515, 21.91% below its average volume of 1044370.

Novo Nordisk A/S’s last close was $95.88, 10.59% below its 52-week high of $107.24.

Novo Nordisk A/S’s Sales

Novo Nordisk A/S’s sales growth is 7.9% for the ongoing quarter and 11.2% for the next. The company’s growth estimates for the present quarter and the next is 6.9% and 12.5%, respectively.

Novo Nordisk A/S’s Revenue

Year-on-year quarterly revenue growth grew by 10.1%, now sitting on 129.91B for the twelve trailing months.

Volatility

Novo Nordisk A/S’s last week, last month’s, and last quarter’s current volatility was a negative 2.61%, a negative 0.54%, and a positive 1.18%, respectively.

Novo Nordisk A/S’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.61% (last week), 1.13% (last month), and 1.18% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Novo Nordisk A/S’s stock is considered to be overbought (>=80).

Novo Nordisk A/S’s Stock Yearly Top and Bottom Value

Novo Nordisk A/S’s stock is valued at $95.88 at 08:34 EST, way below its 52-week high of $107.24 and way higher than its 52-week low of $63.22.

Novo Nordisk A/S’s Moving Average

Novo Nordisk A/S’s value is below its 50-day moving average of $101.44 and way above its 200-day moving average of $85.63.

More news about Novo Nordisk A/S.

7. Entergy Corporation (ETR) – Premarket: 1.24%

NYSE Composite ended the session with Entergy Corporation rising 0.06% to $99.37 on Monday while NYSE Composite rose 1.11% to $16,323.74.

Volume

Today’s last reported volume for Entergy Corporation is 1830550, 30.73% above its average volume of 1400160.

Entergy Corporation’s last close was $99.37, 13.61% under its 52-week high of $115.02.

Entergy Corporation’s Sales

Entergy Corporation’s sales growth is 2.3% for the present quarter and a decline by 2% for the next. The company’s growth estimates for the current quarter is 5.3% and a drop 26.8% for the next.

Entergy Corporation’s Revenue

Year-on-year quarterly revenue growth grew by 17%, now sitting on 10.94B for the twelve trailing months.

Volatility

Entergy Corporation’s last week, last month’s, and last quarter’s current volatility was a negative 6.64%, a negative 6.64%, and a positive 1.18%, respectively.

Entergy Corporation’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 6.70% (last week), 6.70% (last month), and 1.18% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Entergy Corporation’s stock is considered to be oversold (<=20).

Entergy Corporation’s Stock Yearly Top and Bottom Value

Entergy Corporation’s stock is valued at $99.37 at 08:34 EST, way under its 52-week high of $115.02 and way above its 52-week low of $85.78.

Entergy Corporation’s Moving Average

Entergy Corporation’s value is below its 50-day moving average of $109.85 and below its 200-day moving average of $105.57.

More news about Entergy Corporation.

8. CME Group (CME) – Premarket: 1.22%

NASDAQ Composite ended the session with CME Group rising 1.66% to $196.59 on Monday, following the last session’s upward trend. NASDAQ Composite rose 0.82% to $14,566.70, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

Volume

Today’s last reported volume for CME Group is 1252320, 2.66% below its average volume of 1286660.

CME Group’s last close was $196.59, 11.37% under its 52-week high of $221.82.

The company’s growth estimates for the present quarter and the next is 17.4% and 18.7%, respectively.

CME Group’s Revenue

Year-on-year quarterly revenue growth declined by 0.2%, now sitting on 4.6B for the twelve trailing months.

Volatility

CME Group’s last week, last month’s, and last quarter’s current volatility was a negative 0.12%, a positive 0.06%, and a positive 0.79%, respectively.

CME Group’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.95% (last week), 0.82% (last month), and 0.79% (last quarter), respectively.

CME Group’s Stock Yearly Top and Bottom Value

CME Group’s stock is valued at $196.59 at 08:34 EST, way below its 52-week high of $221.82 and way above its 52-week low of $146.89.

CME Group’s Moving Average

CME Group’s value is above its 50-day moving average of $195.96 and under its 200-day moving average of $206.66.

More news about CME Group.

9. United Airlines (UAL) – Premarket: 1.05%

NASDAQ Composite ended the session with United Airlines rising 7.93% to $51.34 on Monday while NASDAQ Composite rose 0.82% to $14,566.70.

Volume

Today’s last reported volume for United Airlines is 21274200, 81.29% above its average volume of 11734700.

United Airlines’s last close was $51.34, 19.4% below its 52-week high of $63.70.

United Airlines’s Sales

United Airlines’s sales growth is 237.4% for the present quarter and 162% for the next. The company’s growth estimates for the current quarter and the next is 99.4% and 103.3%, respectively.

United Airlines’s Revenue

Year-on-year quarterly revenue growth grew by 270.9%, now sitting on 14.59B for the twelve trailing months.

Volatility

United Airlines’s last week, last month’s, and last quarter’s current volatility was 5.43%, 5.43%, and 2.28%, respectively.

United Airlines’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.43% (last week), 5.43% (last month), and 2.28% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

United Airlines’s stock is considered to be oversold (<=20).

United Airlines’s Stock Yearly Top and Bottom Value

United Airlines’s stock is valued at $51.34 at 08:34 EST, way under its 52-week high of $63.70 and way higher than its 52-week low of $32.16.

United Airlines’s Moving Average

United Airlines’s value is way above its 50-day moving average of $46.12 and under its 200-day moving average of $51.83.

More news about United Airlines.

10. American Airlines (AAL) – Premarket: 1.02%

NASDAQ Composite ended the session with American Airlines jumping 5.51% to $21.65 on Monday, following the last session’s upward trend. NASDAQ Composite jumped 0.82% to $14,566.70, following the last session’s upward trend on what was a somewhat up trend exchanging session today.

Volume

Today’s last reported volume for American Airlines is 36233200, 14.4% above its average volume of 31672100.

American Airlines’s last close was $21.65, 17.02% under its 52-week high of $26.09.

American Airlines’s Sales

American Airlines’s sales growth is 225.8% for the ongoing quarter and 136.2% for the next. The company’s growth estimates for the current quarter and the next is 80.5% and 83.4%, respectively.

American Airlines’s Revenue

Year-on-year quarterly revenue growth grew by 361%, now sitting on 18.69B for the twelve trailing months.

Volatility

American Airlines’s last week, last month’s, and last quarter’s current volatility was 0.23%, 0.48%, and 2.38%, respectively.

American Airlines’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.52% (last week), 2.35% (last month), and 2.38% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

American Airlines’s stock is considered to be oversold (<=20).

American Airlines’s Stock Yearly Top and Bottom Value

American Airlines’s stock is valued at $21.65 at 08:34 EST, way below its 52-week high of $26.09 and way above its 52-week low of $10.63.

American Airlines’s Moving Average

American Airlines’s value is above its 50-day moving average of $19.86 and higher than its 200-day moving average of $21.63.

More news about American Airlines.

Most Active Premarket Losers Today

1. Moderna (MRNA) – Premarket: -4.71%

NASDAQ Composite ended the session with Moderna sliding 11.37% to $341.09 on Monday while NASDAQ Composite rose 0.82% to $14,566.70.

Volume

Today’s last reported volume for Moderna is 34170600, 82.85% above its average volume of 18687300.

Moderna’s last close was $341.09, 31.44% under its 52-week high of $497.49.

Moderna’s Sales

Moderna’s sales growth is 8216.6% for the ongoing quarter and 1202.8% for the next. The company’s growth estimates for the ongoing quarter and the next is 1694.9% and 1681.2%, respectively.

Moderna’s Revenue

Year-on-year quarterly revenue growth grew by 6398.5%, now sitting on 7.02B for the twelve trailing months.

Volatility

Moderna’s last week, last month’s, and last quarter’s current volatility was a negative 10.55%, a negative 10.55%, and a positive 4.73%, respectively.

Moderna’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 10.55% (last week), 10.55% (last month), and 4.73% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Moderna’s stock is considered to be overbought (>=80).

Moderna’s Stock Yearly Top and Bottom Value

Moderna’s stock is valued at $341.09 at 08:34 EST, way below its 52-week high of $497.49 and way above its 52-week low of $65.49.

Moderna’s Moving Average

Moderna’s worth is way below its 50-day moving average of $409.37 and way higher than its 200-day moving average of $262.62.

Previous days news about Moderna

  • Japan Moderna supplier takeda plans its second-biggest yen bond. According to Bloomberg Quint on Friday, 1 October, "Takeda Pharmaceutical Co., a drugmaker that distributes Moderna Inc.’s vaccine in Japan, is planning what would be its second-biggest yen bond sale ever next week.", "Japan temporarily suspended the use of Moderna shots in August, and Takeda and Moderna said Friday that their investigation into foreign particles in the vaccine found no undue risk to patient safety. "

More news about Moderna.

2. Arcturus Therapeutics (ARCT) – Premarket: -4.3%

NASDAQ Composite ended the session with Arcturus Therapeutics sliding 7.03% to $44.42 on Monday, after three sequential sessions in a row of losses. NASDAQ Composite rose 0.82% to $14,566.70, following the last session’s upward trend on what was a somewhat up trend trading session today.

Volume

Today’s last reported volume for Arcturus Therapeutics is 598253, 30.57% below its average volume of 861712.

Arcturus Therapeutics’s last close was $44.42, 65.75% below its 52-week high of $129.71.

Arcturus Therapeutics’s Sales

Arcturus Therapeutics’s sales growth is 625.3% for the ongoing quarter and 1814.2% for the next. The company’s growth estimates for the present quarter is a negative 72.8% and positive 6.4% for the next.

Arcturus Therapeutics’s Revenue

Year-on-year quarterly revenue growth declined by 24.6%, now sitting on 9.54M for the twelve trailing months.

Volatility

Arcturus Therapeutics’s last week, last month’s, and last quarter’s current volatility was a negative 10.58%, a negative 10.58%, and a positive 6.55%, respectively.

Arcturus Therapeutics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 10.58% (last week), 10.58% (last month), and 6.55% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Arcturus Therapeutics’s stock is considered to be overbought (>=80).

Arcturus Therapeutics’s Stock Yearly Top and Bottom Value

Arcturus Therapeutics’s stock is valued at $44.42 at 08:34 EST, way below its 52-week high of $129.71 and way above its 52-week low of $24.87.

Arcturus Therapeutics’s Moving Average

Arcturus Therapeutics’s value is way under its 50-day moving average of $52.06 and way above its 200-day moving average of $39.78.

More news about Arcturus Therapeutics.

3. Novavax (NVAX) – Premarket: -3.77%

NASDAQ Composite ended the session with Novavax falling 12.4% to $181.60 on Monday while NASDAQ Composite jumped 0.82% to $14,566.70.

Volume

Today’s last reported volume for Novavax is 17467700, 259.36% above its average volume of 4860720.

Novavax’s last close was $181.60, 45.25% below its 52-week high of $331.68.

News about Novavax today

  • Stocks making the biggest moves in the premarket: Tesla, Moderna, Novavax, GM and more. According to today’s article on CNBC, "Moderna (MRNA), Novavax (NVAXModerna and Novavax shares are under pressure once again this morning. "

The company’s growth estimates for the current quarter is a negative 21.8% and positive 213.7% for the next.

Novavax’s Revenue

Year-on-year quarterly revenue growth grew by 738.6%, now sitting on 1.18B for the twelve trailing months.

Volatility

Novavax’s last week, last month’s, and last quarter’s current volatility was a negative 17.74%, a negative 17.74%, and a positive 5.72%, respectively.

Novavax’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 17.74% (last week), 17.74% (last month), and 5.72% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Novavax’s stock is considered to be overbought (>=80).

Novavax’s Stock Yearly Top and Bottom Value

Novavax’s stock is valued at $181.60 at 08:34 EST, way under its 52-week high of $331.68 and way higher than its 52-week low of $76.59.

Novavax’s Moving Average

Novavax’s worth is way under its 50-day moving average of $237.20 and way below its 200-day moving average of $202.07.

More news about Novavax.

4. Canaan (CAN) – Premarket: -3.12%

NASDAQ Composite ended the session with Canaan jumping 4.91% to $6.41 on Monday, following the last session’s upward trend. NASDAQ Composite jumped 0.82% to $14,566.70, following the last session’s upward trend on what was a somewhat bullish trend trading session today.

Volume

Today’s last reported volume for Canaan is 6128140, 13.59% below its average volume of 7092220.

Canaan’s last close was $6.41, 83.61% below its 52-week high of $39.10.

Canaan’s Revenue

Year-on-year quarterly revenue growth grew by 489.9%, now sitting on 782.19M for the twelve trailing months.

Volatility

Canaan’s last week, last month’s, and last quarter’s current volatility was a negative 25.45%, a negative 25.45%, and a positive 6.48%, respectively.

Canaan’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 30.36% (last week), 30.36% (last month), and 6.48% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Canaan’s stock is considered to be oversold (<=20).

Canaan’s Stock Yearly Top and Bottom Value

Canaan’s stock is valued at $6.41 at 08:34 EST, way under its 52-week high of $39.10 and way above its 52-week low of $1.84.

Canaan’s Moving Average

Canaan’s worth is way under its 50-day moving average of $8.24 and way under its 200-day moving average of $10.70.

More news about Canaan.

5. Seattle Genetics (SGEN) – Premarket: -2.7%

NASDAQ Composite ended the session with Seattle Genetics rising 2.01% to $173.21 on Monday, after two sequential sessions in a row of gains. NASDAQ Composite jumped 0.82% to $14,566.70, following the last session’s upward trend on what was a somewhat up trend trading session today.

Volume

Today’s last reported volume for Seattle Genetics is 1011770, 35.22% above its average volume of 748238.

Seattle Genetics’s last close was $173.21, 19.04% below its 52-week high of $213.94.

The company’s growth estimates for the present quarter and the next is a negative 116.3% and a negative 166.7%, respectively.

Seattle Genetics’s Revenue

Year-on-year quarterly revenue growth grew by 39.7%, now sitting on 2.38B for the twelve trailing months.

Volatility

Seattle Genetics’s last week, last month’s, and last quarter’s current volatility was 6.78%, 6.78%, and 1.67%, respectively.

Seattle Genetics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 6.78% (last week), 6.78% (last month), and 1.67% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Seattle Genetics’s stock is considered to be oversold (<=20).

Seattle Genetics’s Stock Yearly Top and Bottom Value

Seattle Genetics’s stock is valued at $173.21 at 08:34 EST, way below its 52-week high of $213.94 and way above its 52-week low of $133.20.

Seattle Genetics’s Moving Average

Seattle Genetics’s value is above its 50-day moving average of $159.95 and way higher than its 200-day moving average of $151.35.

More news about Seattle Genetics.

6. Toyota (TM) – Premarket: -2.61%

NYSE Composite ended the session with Toyota dropping 0.07% to $177.62 on Monday, after four sequential sessions in a row of losses. NYSE Composite rose 1.11% to $16,323.74, following the last session’s upward trend on what was an all-around positive trend trading session today.

Volume

Today’s last reported volume for Toyota is 237735, 9.19% above its average volume of 217725.

Toyota’s last close was $177.62, 5.24% below its 52-week high of $187.45.

Toyota’s Revenue

Year-on-year quarterly revenue growth grew by 72.5%, now sitting on 30.55T for the twelve trailing months.

Volatility

Toyota’s last week, last month’s, and last quarter’s current volatility was a negative 0.47%, a negative 0.20%, and a positive 1.10%, respectively.

Toyota’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.47% (last week), 0.96% (last month), and 1.10% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Toyota’s stock is considered to be overbought (>=80).

Toyota’s Stock Yearly Top and Bottom Value

Toyota’s stock is valued at $177.62 at 08:34 EST, under its 52-week high of $187.45 and way higher than its 52-week low of $129.28.

Toyota’s Moving Average

Toyota’s value is below its 50-day moving average of $177.87 and above its 200-day moving average of $169.88.

More news about Toyota.

7. Pinduoduo (PDD) – Premarket: -2.41%

NASDAQ Composite ended the session with Pinduoduo sliding 2.78% to $88.15 on Monday, after four consecutive sessions in a row of losses. NASDAQ Composite rose 0.82% to $14,566.70, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for Pinduoduo is 4471440, 48.17% below its average volume of 8628260.

Pinduoduo’s last close was $88.15, 58.54% under its 52-week high of $212.60.

The company’s growth estimates for the present quarter is a negative 160% and positive 1350% for the next.

Pinduoduo’s Revenue

Year-on-year quarterly revenue growth grew by 89%, now sitting on 85.97B for the twelve trailing months.

Volatility

Pinduoduo’s last week, last month’s, and last quarter’s current volatility was a negative 7.81%, a negative 7.81%, and a positive 3.90%, respectively.

Pinduoduo’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 7.81% (last week), 7.81% (last month), and 3.90% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Pinduoduo’s stock is considered to be overbought (>=80).

Pinduoduo’s Stock Yearly Top and Bottom Value

Pinduoduo’s stock is valued at $88.15 at 08:34 EST, way under its 52-week high of $212.60 and way above its 52-week low of $69.89.

Pinduoduo’s Moving Average

Pinduoduo’s value is under its 50-day moving average of $94.87 and way below its 200-day moving average of $115.57.

More news about Pinduoduo.

8. Xenetic Biosciences (XBIO) – Premarket: -2.4%

NASDAQ Composite ended the session with Xenetic Biosciences jumping 1.46% to $2.08 on Monday, following the last session’s upward trend. NASDAQ Composite rose 0.82% to $14,566.70, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for Xenetic Biosciences is 4028670, 61.2% below its average volume of 10383700.

Xenetic Biosciences’s last close was $2.08, 64.44% under its 52-week high of $5.85.

Xenetic Biosciences’s Sales

Xenetic Biosciences’s sales growth is 72.4% for the current quarter and a decline by 33.8% for the next. The company’s growth estimates for the current quarter and the next is 90% and 6.3%, respectively.

Xenetic Biosciences’s Revenue

Year-on-year quarterly revenue growth grew by 154.7%, now sitting on 746.09k for the twelve trailing months.

Volatility

Xenetic Biosciences’s last week, last month’s, and last quarter’s current volatility was a negative 15.37%, a negative 15.37%, and a positive 8.98%, respectively.

Xenetic Biosciences’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 16.83% (last week), 16.83% (last month), and 8.98% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Xenetic Biosciences’s stock is considered to be oversold (<=20).

Xenetic Biosciences’s Stock Yearly Top and Bottom Value

Xenetic Biosciences’s stock is valued at $2.08 at 08:34 EST, way under its 52-week high of $5.85 and way higher than its 52-week low of $0.76.

Xenetic Biosciences’s Moving Average

Xenetic Biosciences’s value is way below its 50-day moving average of $2.68 and way below its 200-day moving average of $2.37.

More news about Xenetic Biosciences.

9. Pacific Biosciences of California (PACB) – Premarket: -2.28%

NASDAQ Composite ended the session with Pacific Biosciences of California rising 1.14% to $25.84 on Monday, following the last session’s upward trend. NASDAQ Composite jumped 0.82% to $14,566.70, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for Pacific Biosciences of California is 1655370, 11.09% below its average volume of 1862000.

Pacific Biosciences of California’s last close was $25.84, 51.87% under its 52-week high of $53.69.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 63.1% for the ongoing quarter and 39.6% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 50% and a negative 164.9%, respectively.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth grew by 79.2%, now sitting on 105.83M for the twelve trailing months.

Volatility

Pacific Biosciences of California’s last week, last month’s, and last quarter’s current volatility was a negative 10.55%, a negative 10.55%, and a positive 3.90%, respectively.

Pacific Biosciences of California’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 11.69% (last week), 11.69% (last month), and 3.90% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Pacific Biosciences of California’s stock is considered to be oversold (<=20).

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $25.84 at 08:34 EST, way under its 52-week high of $53.69 and way above its 52-week low of $11.22.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s worth is below its 50-day moving average of $28.43 and way under its 200-day moving average of $29.58.

More news about Pacific Biosciences of California.

10. Fox Corporation (FOXA) – Premarket: -2.26%

NASDAQ Composite ended the session with Fox Corporation rising 1.67% to $40.78 on Monday while NASDAQ Composite rose 0.82% to $14,566.70.

Volume

Today’s last reported volume for Fox Corporation is 2339220, 5.15% below its average volume of 2466250.

Fox Corporation’s last close was $40.78, 8.97% under its 52-week high of $44.80.

The company’s growth estimates for the current quarter and the next is a negative 14.4% and a negative 81.2%, respectively.

Fox Corporation’s Revenue

Year-on-year quarterly revenue growth declined by 6.5%, now sitting on 12.44B for the twelve trailing months.

Volatility

Fox Corporation’s last week, last month’s, and last quarter’s current volatility was 5.20%, 5.20%, and 1.36%, respectively.

Fox Corporation’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.20% (last week), 5.20% (last month), and 1.36% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Fox Corporation’s stock is considered to be oversold (<=20).

Fox Corporation’s Stock Yearly Top and Bottom Value

Fox Corporation’s stock is valued at $40.78 at 08:34 EST, below its 52-week high of $44.80 and way higher than its 52-week low of $24.93.

Fox Corporation’s Moving Average

Fox Corporation’s value is higher than its 50-day moving average of $37.36 and above its 200-day moving average of $37.47.

More news about Fox Corporation.

Stay up to date with our premarket winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here